Page last updated: 2024-09-04

mk 996 and candesartan cilexetil

mk 996 has been researched along with candesartan cilexetil in 2 studies

Compound Research Comparison

Studies
(mk 996)
Trials
(mk 996)
Recent Studies (post-2010)
(mk 996)
Studies
(candesartan cilexetil)
Trials
(candesartan cilexetil)
Recent Studies (post-2010) (candesartan cilexetil)
801628151133

Protein Interaction Comparison

ProteinTaxonomymk 996 (IC50)candesartan cilexetil (IC50)
Type-1 angiotensin II receptorOryctolagus cuniculus (rabbit)0.2
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)2.4547
DNA polymerase kappaHomo sapiens (human)7.4
DNA polymerase iotaHomo sapiens (human)6.2
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)5
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.7244

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldberg, MR; Greenlee, WJ; Irvin, JD; Prendergast, K; Smith, RD; Timmermans, PB; Wexler, RR1
Giridhar, R; Murumkar, P; Naik, P; Yadav, MR1

Reviews

2 review(s) available for mk 996 and candesartan cilexetil

ArticleYear
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
    Journal of medicinal chemistry, 1996, Feb-02, Volume: 39, Issue:3

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Receptors, Angiotensin; Structure-Activity Relationship

1996
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
    Bioorganic & medicinal chemistry, 2010, Dec-15, Volume: 18, Issue:24

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan

2010